Lyme HP (Energique, Inc.)


Welcome to the PulseAid listing for the Lyme HP drug offered from Energique, Inc.. This pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
LABELER NAME / MANUFACTURER: Energique, Inc.
NON-PROPRIETARY NAME: Baptisia Tinctoria, Echinacea, Hydrastis Canadensis, Lym D Nosode, Arsenicum Album, Bryonia, Chelidonium Majus
SUBSTANCE NAME: BAPTISIA TINCTORIA; ECHINACEA ANGUSTIFOLIA; GOLDENSEAL; NEISSERIA MENINGITIDIS; JAPANESE ENCEPHALITIS VIRUS; HEPATITIS B VIRUS; BORRELIA BURGDORFERI; ARSENIC TRIOXIDE; BRYONIA ALBA ROOT; CHELIDONIUM M
TYPE: HUMAN PRESCRIPTION DRUG
PHARMA CLASS:
ROUTE: ORAL
DOSAGE FORM: LIQUID
MARKETING CATEGORY NAME: UNAPPROVED HOMEOPATHIC
START MARKETING DATE: 2012-11-29
END MARKETING DATE: 0000-00-00


Lyme HP HUMAN PRESCRIPTION DRUG Details:

Item DescriptionLyme HP from Energique, Inc.
LABELER NAME: Energique, Inc.
DEA SCHEDULE:
ACTIVE STRENGTH: 3; 3; 3; 12; 12; 12; 12; 30; 30; 30; 30; 30; 30; 30; 30; 30([hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_C]/mL; [hp_C]/mL; [hp_C]/mL; [hp_C]/mL; [hp_C]/mL; [hp_C]/mL; [hp_C]/mL; [hp_C]/mL; [hp_C]/mL)
START MARKETING DATE: 2012-11-29
END MARKETING DATE: 0000-00-00
PRODUCT ID: 44911-0048_9eae9a22-a401-4bb0-8f14-0841bf482618
PRODUCT NDC: 44911-0048
APPLICATION NUMBER:

Other BAPTISIA TINCTORIA; ECHINACEA ANGUSTIFOLIA; GOLDENSEAL; NEISSERIA MENINGITIDIS; JAPANESE ENCEPHALITIS VIRUS; HEPATITIS B VIRUS; BORRELIA BURGDORFERI; ARSENIC TRIOXIDE; BRYONIA ALBA ROOT; CHELIDONIUM M Pharmaceutical Manufacturers / Labelers:

Manufacturer / LabelerProprietary Name
Energique, Inc.Lyme HP